Azora Therapeutics, Inc. (AZR)
3.89
+0.18
(+4.85%)
USD |
NASDAQ |
Nov 06, 10:09
Azora Therapeutics Market Cap : 10.21M for Nov. 6, 2026
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| November 05, 2026 | 9.742M |
| November 04, 2026 | 10.63M |
| November 03, 2026 | 10.90M |
| November 02, 2026 | 10.21M |
| October 30, 2026 | 10.00M |
| October 29, 2026 | 12.81M |
| October 28, 2026 | 13.26M |
| October 27, 2026 | 9.742M |
| October 26, 2026 | 9.663M |
| October 23, 2026 | 10.29M |
| October 22, 2026 | 11.08M |
| October 21, 2026 | 10.79M |
| October 20, 2026 | 10.03M |
| October 19, 2026 | 9.506M |
| October 16, 2026 | 9.164M |
| October 15, 2026 | 8.245M |
| October 14, 2026 | 7.878M |
| October 13, 2026 | 8.639M |
| October 12, 2026 | 9.191M |
| October 09, 2026 | 10.24M |
| October 08, 2026 | 10.42M |
| October 07, 2026 | 10.48M |
| October 06, 2026 | 10.45M |
| October 05, 2026 | 11.42M |
| October 02, 2026 | 10.82M |
| Date | Value |
|---|---|
| October 01, 2026 | 10.84M |
| September 30, 2026 | 10.53M |
| September 29, 2026 | 10.90M |
| September 28, 2026 | 10.61M |
| September 25, 2026 | 11.08M |
| September 24, 2026 | 11.66M |
| September 23, 2026 | 10.61M |
| September 22, 2026 | 11.03M |
| September 21, 2026 | 11.55M |
| September 18, 2026 | 12.76M |
| September 17, 2026 | 13.68M |
| September 16, 2026 | 13.76M |
| September 15, 2026 | 13.13M |
| September 14, 2026 | 13.13M |
| September 11, 2026 | 12.87M |
| September 10, 2026 | 15.74M |
| September 09, 2026 | 15.57M |
| September 08, 2026 | 17.46M |
| September 04, 2026 | 18.70M |
| September 03, 2026 | 17.49M |
| September 02, 2026 | 16.60M |
| September 01, 2026 | 15.62M |
| August 31, 2026 | 15.10M |
| August 28, 2026 | 14.70M |
| August 27, 2026 | 14.94M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| ANI Pharmaceuticals, Inc. | 1.612B |
| Corcept Therapeutics, Inc. | 8.060B |
| Veru, Inc. | 35.29M |
| Johnson & Johnson | 653.97B |
| Eli Lilly & Co. | 1.291T |
Market Cap Related Metrics
| PEG Ratio | -0.0098 |
| Price | 3.89 |
| Earnings Yield | -425.3% |
| PEGY Ratio | -0.0098 |